When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MTFB - Motif Bio to evaluate iclaprim in ophthalmology; shares up 8% premarket
Motif Bio plc
Motif Bio (NASDAQ:MTFB) has signed an agreement with Otto-von-Guericke University Magdeburg to conduct a study evaluating iclaprim in an in vitro model of ocular toxoplasmosis.
More news on: Motif Bio plc, Healthcare stocks news, Stocks on the move,